Form 8-K - Current report:
SEC Accession No. 0001639691-24-000139
Filing Date
2024-11-01
Accepted
2024-11-01 17:12:22
Documents
14
Period of Report
2024-11-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K livn-20241101.htm   iXBRL 8-K 24362
5 livn-20241101_g1.jpg GRAPHIC 6904
  Complete submission text file 0001639691-24-000139.txt   170811

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT livn-20241101.xsd EX-101.SCH 1915
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT livn-20241101_lab.xml EX-101.LAB 22588
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT livn-20241101_pre.xml EX-101.PRE 13103
17 EXTRACTED XBRL INSTANCE DOCUMENT livn-20241101_htm.xml XML 2770
Mailing Address 20 EASTBOURNE TERRACE LONDON X0 W2 6LG
Business Address 20 EASTBOURNE TERRACE LONDON X0 W2 6LG 4402033250662
LivaNova PLC (Filer) CIK: 0001639691 (see all company filings)

EIN.: 981268150 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37599 | Film No.: 241419978
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)